Financials in USD. Standardized financial statements.
A compact view of how Meihua International Medical Technologies Co., Ltd. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|
| Revenue? | $96.91M | $97.10M | $103.35M | $104.04M | $89.06M | $79.63M | $75.71M |
| Revenue Growth? | -0.2% | -6.0% | -0.7% | +16.8% | +11.8% | +5.2% | 0.0% |
| Cost of Revenue? | $63.61M | $64.00M | $65.25M | $64.23M | $51.90M | $47.42M | $43.82M |
| Gross Profit? | $33.30M | $33.09M | $38.10M | $39.81M | $37.16M | $32.21M | $31.89M |
| Gross Margin? | +34.4% | +34.1% | +36.9% | +38.3% | +41.7% | +40.5% | +42.1% |
| Operating Expenses? | $18.99M | $18.42M | $22.54M | $14.50M | $13.69M | $12.82M | $13.10M |
| Operating Income? | $14.31M | $14.67M | $10.80M | $26.26M | $23.47M | $19.39M | $19.18M |
| EBITDA? | $15.70M | $15.77M | $11.65M | $27.03M | $24.39M | $19.90M | $19.74M |
| Income Before Tax | $13.63M | $15.05M | $10.89M | $26.23M | $23.73M | $19.25M | $18.71M |
| Income Tax Expense | $2.79M | $3.46M | $4.71M | $5.28M | $4.69M | $3.82M | $3.23M |
| Net Income? | $10.84M | $11.63M | $6.24M | $20.95M | $19.05M | $15.43M | $15.48M |
| EPS? | $40.00 | $49.00 | $27.00 | $89.00 | $79.00 | $64.00 | $77.00 |
| Diluted EPS? | $40.00 | $49.00 | $27.00 | $89.00 | $79.00 | $64.00 | $77.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality